Update Series (2022) Lesson 21: The Changing Role of Fluoroquinolones for Prophylaxis and Treatment of Urological Infections

Audio Lessons - Listen on-the-go for Free!

Did you know you can stream Update Series lessons from your favorite Podcast app (including Apple Podcast and Pocket Casts)?
Add the Update Series Audio Lessons to Your Podcast Library Today!

Please follow the download instructions to your preferred Podcast app, located below.

Apple Podcasts
1. Copy your Personal Subscriber Feed URL*: https://university.auanet.org/updateseries/rssaudio.cfm?userID=
2. Open Apple Podcasts app.
3.点击图标底部的“Library”。
4. Click "…" on the top right corner, and select "Add a Show by URL".
5. Paste your copied personal URL and tap "Follow".

Pocket Casts
1. Copy your Personal Subscriber Feed URL*: https://university.auanet.org/updateseries/rssaudio.cfm?userID=
2. Open Pocket Casts app.
3.在“发现”标签,将你复制的个人feed URL粘贴到搜索栏,然后点击“搜索”。
4. Click on the Update Series Podcast in search results.
5. Click "Subscribe".

*Please note that this URL is individual to you and only available to Update Series 2022 subscribers.

Instructions to stream the Update Series in other Podcast apps.

Access the Audio Lessons are also available in the AUAUniversityapp and within the AUAUlesson Content page.

Download on the App Store Get it on Google Play

Target Audience

  • Urologist
  • Resident

Learning Objectives

At the conclusion of this continuing medical education activity, the participant will be able to define the role of fluoroquinolones in treating urinary tract infections, describe the adverse side effects and complications associated with fluoroquinolones, and manage urinary tract infections employing fluoroquinolones and alternatives.

Course summary
Available credit:
  • 1.00AMA PRA Category 1 Credit™
  • 1.00Non-Physician Participation
Course opens:
08/01/2022
Course expires:
08/31/2025
Rating:
0

Education Council Disclosures

PDF iconEducation Council Disclosures_2022.pdf

COI Review Work Group Disclosures

PDF iconCOI Review Work Group_2022.pdf

Update Series Editorial Committee Disclosures

PDF iconUpdate Series Editorial Committee_2022.pdf

AUA Office of Education Staff has nothing to disclose.

All relevant financial relationships have been mitigated.

Author(s)

Curtis Nickel, MD

has afinancial relationship (Consultant or Advisor (General Urology)) with TEVA; .
has afinancial relationship (Scientific Study or Trial (General Urology)) with Canadian Institute of Health Research; .
has afinancial relationship (Meeting Participant or Lecturer (General Urology)) with UTIVA; .
has afinancial relationship (Consultant or Advisor (General Urology)) with HengRui; .
has afinancial relationship (Scientific Study or Trial (General Urology)) with MicroGenDx; .
has afinancial relationship (Consultant or Advisor (General Urology)) with Seikagaku Corporation; .
has afinancial relationship (Consultant or Advisor (General Urology)) with Farr Laboratories; .
has afinancial relationship (Scientific Study or Trial (General Urology)) with Inmunotek; .
has afinancial relationship (Consultant or Advisor (General Urology)) with Alivio Therapeutics; .
has afinancial relationship (Health Publishing (General Urology)) with AUA; .
has afinancial relationship (Scientific Study or Trial (General Urology)) with RedLeaf Medical; .
has afinancial relationship (Scientific Study or Trial (General Urology)) with NIH; .
has afinancial relationship (Consultant or Advisor (General Urology)) with OM Pharma; .
has afinancial relationship (Consultant or Advisor (General Urology)) with Valensa; .

CME CREDITS EXPIRATION:

Please note: CME Credits expire after three years of original release date. Answers must be submitted by the CME credits expiration deadline to receive credit for that year. Refer to CME expiration table below:

CME Credits Expiration Date

2022 Update Series

Month, 2025

2021 Update Series

Month, 2024

2020 Update Series

Month, 2023

2019 Update Series

Month, 2022

2018 and prior

Not eligible for CME credits.

This self-study continuing medical education activity is designed to provide urologists, Board candidates and/or residents affordable and convenient access to the most recent developments and techniques in urology.

METHOD OF PARTICIPATION:

Participants receive 5 lessons per month for 8 months for a total of 40 lessons. Each lesson is designated for a maximum of 1.0AMA PRA Category 1 Credit™. To earn credit, participants must read the educational material provided for each lesson, pass its corresponding online posttest with at least 80% accuracy, submit the online evaluation and claim CME.

ACCREDITATION:

美国泌尿世界杯英格兰vs伊朗波胆预测外科协会(AUA)是由继续医学教育认证委员会(ACCME)认可的,为医生提供继续医学教育。

CREDIT DESIGNATION:

The American Urological Association designates this enduring activity for a maximum of 40AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

OTHER LEARNERS:

The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified forAMA PRA Category 1 Credit™.

EVIDENCE BASED CONTENT:

It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

AUA DISCLOSURE POLICY:

All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider all financial relationships with any commercial interest during the previous 24 months. The AUA must determine if the individual’s relationships may influence the educational content and mitigate any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

MITIGATION OF IDENTIFIED CONFLICT OF INTEREST:

所有披露的信息将由AUA利益冲突(COI)审查工作组主席和/或副主席审查,以确定利益冲突。联盟的COI审查工作组将与教育办公室工作人员合作,记录管理和缓解利益冲突的机制,并将在实施活动之前记录活动的最终批准。Any of the mechanisms below can/will be used to mitigate conflict of interest:

  • Peer review for valid, evidence-based content by the AUA COI Review Work Group.
  • Attestation that clinical recommendations are evidence-based and free of commercial bias.
  • Introduction of a debate format (point-counterpoint)
  • Inclusion of moderated panel discussion with unbiased moderator
  • Publication of a parallel or rebuttal article for an article that is felt to be biased
  • Divestiture of the relationship by faculty
  • Recusal from controlling relevant aspects of planning
  • Selection of alternative faculty for specific topic

OFF-LABEL OR UNAPPROVED USE OF DRUGS OR DEVICES:

The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

REPRODUCTION PERMISSION:

Reproduction of written materials developed for this AUA activity is prohibited without the written permission from individual authors and the American Urological Association.

PEER REVIEW:

Peer review is the principle mechanism by which the quality of the AUA Update Series content is judged by the AUA Update Series Editorial Committee.

Released date: August, 2022
Expiration date: August, 2025

Available Credit

  • 1.00AMA PRA Category 1 Credit™
  • 1.00Non-Physician Participation
Pleaseloginorregister上这门课。